Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-24-006905
Filing Date
2024-09-09
Accepted
2024-09-09 16:31:12
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3322
  Complete submission text file 0001950047-24-006905.txt   4776
Mailing Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139
Business Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139 617-586-3100
Foghorn Therapeutics Inc. (Subject) CIK: 0001822462 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-39634 | Film No.: 241287622
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139
Business Address
Bellon Steven F. (Reporting) CIK: 0001831749 (see all company filings)

Type: 144